Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

8 projects found matching your search criteria :

  1. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig...

    Call: SONATA 1 , Panel: NZ2

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  2. Halogen bonding - the role and significance in interactions of ligands with class A GPCRs

    Call: SONATA 8 , Panel: NZ7

    Principal investigator: dr Rafał Kurczab

    Instytut Farmakologii PAN

  3. Study of interaction and signal passing in complexes of GPCRs with arrestin

    Call: HARMONIA 4 , Panel: ST6

    Principal investigator: prof. Sławomir Filipek

    Uniwersytet Warszawski, Wydział Chemii

  4. Study of ligand binding and activation processes of formyl, opioid and cannabinoid G-protein-coupled receptors

    Call: OPUS 2 , Panel: NZ1

    Principal investigator: prof. Sławomir Filipek

    Uniwersytet Warszawski, Wydział Chemii

  5. Chimeric Rhodopsin as a novel optogenetic tool

    Call: SONATINA 7 , Panel: NZ5

    Principal investigator: dr Jagoda Płaczkiewicz

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  6. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  7. Novel ligands of histamine receptor H4 as potential anti-allergic and anti-inflammatory drugs

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Sławomir Filipek

    Uniwersytet Warszawski, Wydział Chemii

  8. Molecular mechanism of interactions between GPCRs and G protein.

    Call: PRELUDIUM 10 , Panel: NZ2

    Principal investigator: Stefan Mordalski

    Instytut Farmakologii Polskiej Akademii Nauk